Macquarie Group LTD Intra Cellular Therapies, Inc. Transaction History

Macquarie Group LTD

  • $87.4 Billion
  • Q1 2024

A detailed history of Macquarie Group LTD transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 1,462,380 shares of ITCI stock, worth $100 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,462,380
Previous 1,564,153 6.51%
Holding current value
$100 Million
Previous $112 Million 9.67%
% of portfolio
0.12%
Previous 0.13%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$64.37 - $75.65 $6.55 Million - $7.7 Million
-101,773 Reduced 6.51%
1,462,380 $101 Million
Q4 2023

Feb 14, 2024
BUY
$46.37 - $73.65 $9.12 Million - $14.5 Million
196,778 Added 14.39%
1,564,153 $112 Million
Q3 2023

Nov 14, 2023
BUY
$52.09 - $64.1 $18.2 Million - $22.4 Million
348,978 Added 34.27%
1,367,375 $71.2 Million
Q2 2023

Aug 14, 2023
BUY
$54.67 - $66.44 $31.1 Million - $37.8 Million
568,397 Added 126.31%
1,018,397 $64.5 Million
Q4 2022

Feb 21, 2023
SELL
$44.07 - $54.45 $84,614 - $104,544
-1,920 Reduced 0.42%
450,000 $23.8 Million
Q3 2022

Nov 14, 2022
SELL
$42.7 - $59.99 $3.16 Million - $4.44 Million
-74,053 Reduced 14.08%
451,920 $21.1 Million
Q2 2022

Aug 15, 2022
BUY
$43.0 - $65.64 $3.17 Million - $4.84 Million
73,801 Added 16.32%
525,973 $30 Million
Q1 2022

May 16, 2022
BUY
$38.74 - $62.09 $28,318 - $45,387
731 Added 0.16%
452,172 $27.7 Million
Q2 2021

Aug 13, 2021
SELL
$29.3 - $44.5 $21,183 - $32,173
-723 Reduced 0.16%
451,441 $18.4 Million
Q1 2021

May 14, 2021
SELL
$30.8 - $39.51 $22,360 - $28,684
-726 Reduced 0.16%
452,164 $15.3 Million
Q3 2020

Nov 13, 2020
BUY
$17.61 - $31.86 $2.99 Million - $5.42 Million
170,000 Added 60.09%
452,890 $11.6 Million
Q2 2020

Aug 11, 2020
BUY
$14.35 - $26.64 $687,221 - $1.28 Million
47,890 Added 20.38%
282,890 $7.26 Million
Q1 2020

May 15, 2020
BUY
$12.31 - $33.12 $1.66 Million - $4.47 Million
135,000 Added 135.0%
235,000 $3.61 Million
Q3 2019

Nov 14, 2019
SELL
$7.47 - $14.03 $56,891 - $106,852
-7,616 Reduced 7.08%
100,000 $747,000
Q2 2019

Aug 14, 2019
BUY
$10.65 - $14.29 $349,320 - $468,712
32,800 Added 43.84%
107,616 $1.4 Million
Q4 2018

Feb 15, 2019
BUY
$10.36 - $20.96 $231,028 - $467,408
22,300 Added 42.46%
74,816 $852,000
Q3 2018

Nov 15, 2018
SELL
$17.77 - $22.9 $51,337 - $66,158
-2,889 Reduced 5.21%
52,516 $1.14 Million
Q2 2018

Aug 14, 2018
SELL
$17.33 - $23.4 $6,481 - $8,751
-374 Reduced 0.67%
55,405 $979,000
Q1 2018

May 11, 2018
BUY
$15.16 - $25.49 $813,773 - $1.37 Million
53,679 Added 2556.14%
55,779 $1.17 Million
Q4 2017

Feb 15, 2018
BUY
$14.27 - $16.79 $29,967 - $35,259
2,100
2,100 $30,000

Others Institutions Holding ITCI

# of Institutions
381
Shares Held
77.7M
Call Options Held
1.7M
Put Options Held
1.13M
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $6.47B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email